The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research
The newly proposed glioma stem cell (GSC) hypothesis may re-model the way we diagnose and treat the tumor, which highlights the need for a complete knowledge on the genetic and epigenetic “blueprints” of GSCs. To identify the true “stemness” signatures, pure GSC populations are primarily needed. Rel...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
02 August 2010
|
| In: |
Brain pathology
Year: 2010, Jahrgang: 20, Heft: 5, Pages: 877-889 |
| ISSN: | 1750-3639 |
| DOI: | 10.1111/j.1750-3639.2010.00379.x |
| Online-Zugang: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1111/j.1750-3639.2010.00379.x Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1750-3639.2010.00379.x 
|
| Verfasserangaben: | Feng Wan, Suojun Zhang, Ruifan Xie, Baocheng Gao, Benito Campos, Christel Herold-Mende, Ting Lei |
| Zusammenfassung: | The newly proposed glioma stem cell (GSC) hypothesis may re-model the way we diagnose and treat the tumor, which highlights the need for a complete knowledge on the genetic and epigenetic “blueprints” of GSCs. To identify the true “stemness” signatures, pure GSC populations are primarily needed. Reliable in vitro methods enriching for GSCs and thereby identifying the key stem-like characteristics constitute the preliminary step forward. We discuss in this review the current widely used methods for enriching and isolating GSCs, namely neurosphere assay, CD133 Immunophenotyping and side population assay, and detail their limitations and potential pitfalls that could complicate interpretation of corresponding results. |
|---|---|
| Beschreibung: | Gesehen am 10.10.2023 |
| Beschreibung: | Online Resource |
| ISSN: | 1750-3639 |
| DOI: | 10.1111/j.1750-3639.2010.00379.x |